These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35282101)

  • 1. Establishment of a molecular risk model for the prognosis of cervical cancer based on microRNA expression.
    Li J; Liang L; Xiu L; Zeng J; Zhu Y; An J; Wu L
    Ann Transl Med; 2022 Jan; 10(2):125. PubMed ID: 35282101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Necroptosis-Related miRNA Signature for Predicting the Prognosis of Breast Cancer Metastasis.
    Zheng L; Wang J; Jiang H; Dong H
    Dis Markers; 2022; 2022():3391878. PubMed ID: 35371342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Five-microRNA Signature as Prognostic Biomarker in Colorectal Cancer by Bioinformatics Analysis.
    Yang G; Zhang Y; Yang J
    Front Oncol; 2019; 9():1207. PubMed ID: 31799184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A microRNA-clinical prognosis model to predict the overall survival for kidney renal clear cell carcinoma.
    Zhan Y; Zhang R; Li C; Xu X; Zhu K; Yang Z; Zheng J; Guo Y
    Cancer Med; 2021 Sep; 10(17):6128-6139. PubMed ID: 34288551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishing a three-miRNA signature as a prognostic model for colorectal cancer through bioinformatics analysis.
    Wang Y; Huang L; Shan N; Ma H; Lu S; Chen X; Long H
    Aging (Albany NY); 2021 Aug; 13(15):19894-19907. PubMed ID: 34388112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six MicroRNA Prognostic Models for Overall Survival of Lung Adenocarcinoma.
    Li J; Gu X; Gao C; Zhang J
    Genet Res (Camb); 2022; 2022():5955052. PubMed ID: 36101742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A microRNA-Messenger RNA Regulatory Network and Its Prognostic Value in Cervical Cancer.
    Liu J; Yang J; Gao F; Li S; Nie S; Meng H; Sun R; Wan Y; Jiang Y; Ma X; Cheng W
    DNA Cell Biol; 2020 Jul; 39(7):1328-1346. PubMed ID: 32456463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinformatic analysis and
    Li W; Kong X; Huang T; Shen L; Wu P; Chen QF
    Ann Transl Med; 2020 Nov; 8(21):1422. PubMed ID: 33313167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic analyses of a novel circRNA-related miRNAs prognostic signature for Cervical Cancer.
    Wang S; Zhang S
    Genet Mol Biol; 2022; 45(2):e20210405. PubMed ID: 35766420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A six-microRNA signature can better predict overall survival of patients with esophagus adenocarcinoma.
    Lan T; Lu Y; Xiao Z; Xu H; He J; Hu Z; Mao W
    PeerJ; 2019; 7():e7353. PubMed ID: 31380150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Defined Necroptosis-Related miRNAs Signature for Predicting the Prognosis of Colon Cancer.
    Yang Z; Lu S; Wang Y; Tang H; Wang B; Sun X; Qu J; Rao B
    Int J Gen Med; 2022; 15():555-565. PubMed ID: 35046713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of a miRNA-Based Nomogram Model to Predict the Prognosis of Endometrial Cancer.
    Ni L; Tang C; Wang Y; Wan J; Charles MG; Zhang Z; Li C; Zeng R; Jin Y; Song P; Wei M; Li B; Zhang J; Wu Z
    J Pers Med; 2022 Jul; 12(7):. PubMed ID: 35887651
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of prognostic markers for hepatocellular carcinoma based on miRNA expression profiles.
    Wang X; Gao J; Zhou B; Xie J; Zhou G; Chen Y
    Life Sci; 2019 Sep; 232():116596. PubMed ID: 31233760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. hsa-mir-3199-2 and hsa-mir-1293 as Novel Prognostic Biomarkers of Papillary Renal Cell Carcinoma by COX Ratio Risk Regression Model Screening.
    Luo W; Wang L; Luo MH; Huang YZ; Yang H; Zhou Y; Jia HT; Wang XX
    J Cell Biochem; 2017 Oct; 118(10):3488-3494. PubMed ID: 28338236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated Analysis Identifies a Nine-microRNA Signature Biomarker for Diagnosis and Prognosis in Colorectal Cancer.
    Di Z; Di M; Fu W; Tang Q; Liu Y; Lei P; Gu X; Liu T; Sun M
    Front Genet; 2020; 11():192. PubMed ID: 32265979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A risk score system based on a six-microRNA signature predicts the overall survival of patients with ovarian cancer.
    Zhou M; Wu T; Yuan Y; Dong SJ; Zhang ZM; Wang Y; Wang J
    J Ovarian Res; 2022 May; 15(1):54. PubMed ID: 35513874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-95-3p acts as a prognostic marker and promotes cervical cancer progression by targeting VCAM1.
    Feng S; Lu Y; Sun L; Hao S; Liu Z; Yang F; Zhang L; Wang T; Jiang L; Zhang J; Liu S; Pang H; Wang Z; Wang H
    Ann Transl Med; 2022 Nov; 10(21):1171. PubMed ID: 36467343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide analysis to identify a novel microRNA signature that predicts survival in patients with stomach adenocarcinoma.
    Luo SS; Liao XW; Zhu XD
    J Cancer; 2019; 10(25):6298-6313. PubMed ID: 31772663
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of candidate miRNA biomarkers correlated with the prognosis of cell carcinoma and endocervical adenocarcinoma via integrated bioinformatics analysis.
    Zhi S; Jiang B; Yu W; Li Y; Wang H; Zhou T; Li N
    Am J Transl Res; 2022; 14(11):8146-8155. PubMed ID: 36505295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mir-421 and mir-550a-1 are potential prognostic markers in esophageal adenocarcinoma.
    Ji Y; Wang L; Chang G; Yan J; Dai L; Ji Z; Liu J; He M; Xu H; Zhang L
    Biol Direct; 2023 Feb; 18(1):5. PubMed ID: 36829221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.